title: Effect of p53 inhibition by pifithrin-alpha on functional activity of vasopressin neurones in rat hypothalamus.
abstract: In the present work we investigated the effects of p53 inhibition by pifithrin-alpha (PFT) in vitro and in vivo on functioning vasopressinergic magnocellular neurones of rat hypothalamus. In vivo treatments with PFT were done by intra-hypothalamic microinjections or by intra peritoneal injections. In in vitro experiments hypothalamic slices containing supraoptic nuclei and intact pituitary were incubated with or without PFT. In all experiments we observed accumulation of vasopressin (VP) in the cell perikarya after PFT injections, however expression of VP mRNA was not changed. Analysis of VP content in the posterior pituitary demonstrated that amount of VP was significantly decreased after PFT treatments. Additionally, long-term inhibition of p53 in experiments with intra-hypothalamic injections of PFT resulted in an increased diuresis rate. The obtained results demonstrated that in all experiments PFT treatments inhibited VP anterograde transport from the cells of supraoptic nuclei. Moreover, analysis of MEK/ERK activities revealed that phosphorylation levels of MEK1/2 and ERK1/2 were decreased after PFT treatments. Our findings provide new evidences that p53 could be involved in the control of VP secretion from hypothalamo-hypophyseal system and that this action probably can be mediated by ERK signalling pathway.
authors.forename: N A
authors.initials: NA
authors.lastname: Dorofeeva
authors.forename: E V
authors.initials: EV
authors.lastname: Chernigovskaya
authors.forename: L S
authors.initials: LS
authors.lastname: Nikitina
authors.forename: M
authors.initials: M
authors.lastname: Glazova
mesh_terms: D000818:Animals; D052160:Benzothiazoles / Q000008:administration & dosage*; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism; D020935:MAP Kinase Signaling System / Q000187:drug effects; D008297:Male; D009474:Neurons / Q000187:drug effects*; D051381:Rats; D013495:Supraoptic Nucleus / Q000187:drug effects / Q000378:metabolism; D014050:Toluene / Q000008:administration & dosage / Q000031:analogs & derivatives*; D016159:Tumor Suppressor Protein p53 / Q000037:antagonists & inhibitors / Q000378:metabolism*; D014667:Vasopressins / Q000378:metabolism*
chemical_list: D052160:Benzothiazoles; D016159:Tumor Suppressor Protein p53; D014667:Vasopressins; D014050:Toluene; C121565:pifithrin